Takeaways
#- Verona’s multi-year breakout and relative strength made it both hosts’ favorite, with $25 defining the idea and $35–$40 the prospective target zone.
- Pennant’s weekly momentum confirmed the trend, while a daily divergence still needed price confirmation.
- Check Point’s strong primary uptrend did not make its extended near-term entry automatically attractive.
- Twist needed to clear roughly $58–$60 and its anchored VWAP before the hosts would treat its reversal as more convincing.
Verona Pharma (VRNA) was breaking out while much of the market struggled. That contrast made it the favorite chart for both Patrick Dunuwila and Alfonso DePablos during the September 10, 2024 Chart Request Live.
Verona’s $25 level defined the setup
Looking back toward 2018 revealed the scale of Verona’s base. The hosts described a multi-year cup-and-handle formation that had recently resolved higher, with momentum supporting the breakout.
Dunuwila used $25 as the key condition. Above it, he saw potential toward $35 to $40. He described that upper zone as an area to consider taking some profits, reducing the position or raising a stop, rather than assuming the stock would continue indefinitely.
DePablos emphasized the value of knowing where the idea would be wrong before entering. He also liked the stock’s relative strength: if it could hold up while the broader market was under pressure, it could be well placed when that pressure eased.
Pennant’s momentum signals depended on the timeframe
The Pennant Group (PNTG) had a persistent uptrend from its late-2023 low. It was approaching an older pivot that had served as both support and resistance, making the next price response important.
On the weekly chart, the relative strength index was making higher highs alongside price. Dunuwila regarded that as confirmation of the advance. The daily chart prompted a different question: should a possible bearish momentum divergence change their view?
DePablos wanted price to confirm the warning. A break below the July pivot high would make him more cautious. If that happened alongside RSI moving toward oversold readings, he would see a more substantial change in the stock’s behavior.
Until then, the broader momentum pattern remained constructive. The hosts noted that daily RSI had tended to stay in the upper portion of its range, around 50 and above, and had held there through the recent pullback. A divergence alone had not persuaded them that the uptrend was finished.
Check Point’s uptrend could still need a pause
Check Point Software Technologies (CHKP) illustrated a different entry problem. Its long consolidation had finally resolved higher, and software was holding up better than semiconductors. Yet the rally had brought the stock to an extension where the hosts thought it might consolidate.
Dunuwila said someone choosing to enter there could use roughly $180–$185 as a nearby risk reference, while expecting potential choppiness. He was more inclined to take some money off at that point than start a fresh position.
DePablos agreed that the short-term move looked extended. He still saw a strong primary trend, however, with no completed top or failed breakout that would make him want to short it. Waiting for a better entry was compatible with liking the trend.
Twist’s reversal needed more work
Twist Bioscience (TWST) had tried to clear the neckline of a possible head-and-shoulders bottom and failed. The rejection also occurred near VWAP anchored to the stock’s all-time high, giving the hosts another reason to respect the area.
They wanted a decisive move above roughly $58–$60, which would also clear that anchored VWAP. Only then would the upper $80s become the next useful reference.
DePablos preferred to leave it alone until it cleared $60. The rebound from its old lows had been large, but the transition from a severe downtrend to a durable uptrend was still incomplete.
Questions and answers
#Questions about the original 2024-09-10 episode.
Why did Verona stand out to both hosts?
It had broken out of a large multi-year base while the broader market was weak. They liked the relative strength and used $25 as a clear reference for the setup, with a possible move toward $35–$40.
What would confirm the warning in Pennant’s daily momentum?
DePablos wanted price to break below the July pivot high. A subsequent move in RSI toward oversold readings would add evidence that the stock’s bullish behavior was changing.
Why did the hosts want to wait on Twist?
Its attempted bottom had been rejected near the neckline and VWAP anchored to the all-time high. They wanted a decisive move above roughly $58–$60 before considering the upper $80s as the next reference.
Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .